Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,000 | |||
5 mg | 在庫あり | ¥ 21,000 | |||
10 mg | 在庫あり | ¥ 30,500 | |||
25 mg | 在庫あり | ¥ 60,500 | |||
50 mg | 在庫あり | ¥ 108,500 | |||
100 mg | 在庫あり | ¥ 159,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 36,500 |
説明 | Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure. |
ターゲット&IC50 | PDE3:5.9 μM (IC50), PDE4A:21.1 μM (IC50, myocardial PDE4A) |
In vivo | Perioperative Enoximone administration improved renal function in patients undergoing on-pump cardiac surgery. |
分子量 | 248.3 |
分子式 | C12H12N2O2S |
CAS No. | 77671-31-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.48 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enoximone 77671-31-9 Metabolism PDE inhibit bronchodilatory CD11b eosinophils vasodilating Phosphodiesterase (PDE) airway cAMP PDE3 PDE4A Inhibitor anti-inflammatory Antiasthma inhibitor